In-house preparation of macroaggregated albumin (MAA) for 68Ga labeling and its comparison with commercially available MAA
Akanksha Jain(Bhabha Atomic Research Centre), Ashutosh Dash(Bhabha Atomic Research Centre), Usha Pandey(Bhabha Atomic Research Centre), Haladhar Dev Sarma(Bhabha Atomic Research Centre), Ramu Ram(Bhabha Atomic Research Centre), Suresh Subramanian(Bhabha Atomic Research Centre)
Cited by 11
Related Papers
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
|Nuclear Medicine and Molecular Imaging|2015|375
Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward
|Journal of Nuclear Medicine|2012|140
Peptide Receptor Radionuclide Therapy: An Overview
|Cancer Biotherapy and Radiopharmaceuticals|2015|122
Targeted Radionuclide Therapy - An Overview
|Current Radiopharmaceuticals|2013|117
Development of an electrochemical 90Sr–90Y generator for separation of 90Y suitable for targeted therapy
|Nuclear Medicine and Biology|2008|99